Standard Chemical & Pharmaceutical Management
Management criteria checks 0/4
Standard Chemical & Pharmaceutical's CEO is Tzu-Ting Fan, appointed in Jul 2008, has a tenure of 16.58 years. directly owns 6.58% of the company’s shares, worth NT$728.35M. The average tenure of the management team and the board of directors is 1.9 years and 1.1 years respectively.
Key information
Tzu-Ting Fan
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 16.6yrs |
| CEO ownership | 6.6% |
| Management average tenure | 1.9yrs |
| Board average tenure | 1.1yrs |
Recent management updates
Recent updates
Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70
Jul 29
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70
Jul 14If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late
Apr 13A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)
Mar 14Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?
Mar 01Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?
Feb 16
Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?
Feb 03Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Jan 19Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today
Jan 04Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?
Dec 22A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)
Dec 08Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly
Nov 26CEO
Tzu-Ting Fan
16.6yrs
Tenure
Mr. Tzu-Ting Fan serves as Chairman of the Board since June 28, 2024 and serves as its General Manager Standard Chem. & Pharm. Co., Ltd.and its President since July 1, 2008. He served as Director at Stand...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 16.6yrs | no data | 6.58% NT$ 728.4m | |
| Financial Officer | 1.9yrs | no data | no data | |
| GM & Director | 1.9yrs | no data | no data |
1.9yrs
Average Tenure
Experienced Management: 1720's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | less than a year | no data | 6.58% NT$ 728.4m | |
| GM & Director | less than a year | no data | no data | |
| Director | no data | no data | no data | |
| Director | 1.1yrs | no data | 0.052% NT$ 5.8m | |
| Independent Director | no data | no data | no data | |
| Director | 4.1yrs | no data | no data | |
| Independent Director | 3.5yrs | no data | no data | |
| Additional Independent Director | 1.7yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 1.1yrs | no data | no data |
1.1yrs
Average Tenure
Experienced Board: 1720's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 08:44 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Standard Chemical & Pharmaceutical Co. Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Qing Rong Lin | E.Sun Securities Investment Consulting Co. Ltd. |
| Regina Lee | IBTS Investment Consulting Co., Ltd. |
| Li-chun Chang | Jih Sun Securities Investment Consulting Co., Ltd. |